Shares of Theralase Technologies Inc. (CVE:TLT – Get Free Report) were up 21.1% during mid-day trading on Monday . The stock traded as high as C$0.23 and last traded at C$0.23. Approximately 222,201 shares traded hands during trading, an increase of 98% from the average daily volume of 112,319 shares. The stock had previously closed at C$0.19.
Theralase Technologies Stock Performance
The company has a current ratio of 1.21, a quick ratio of 3.40 and a debt-to-equity ratio of 20.58. The firm has a market capitalization of C$78.57 million, a price-to-earnings ratio of -14.00 and a beta of 1.36. The company has a 50-day moving average of C$0.19 and a 200-day moving average of C$0.18.
Theralase Technologies (CVE:TLT – Get Free Report) last posted its quarterly earnings results on Monday, August 12th. The company reported C($0.01) earnings per share (EPS) for the quarter. The company had revenue of C$0.10 million during the quarter. On average, equities research analysts forecast that Theralase Technologies Inc. will post -0.05 earnings per share for the current fiscal year.
Theralase Technologies Company Profile
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Articles
- Five stocks we like better than Theralase Technologies
- Do ETFs Pay Dividends? What You Need to Know
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Profitably Trade Stocks at 52-Week Highs
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Using the MarketBeat Dividend Yield Calculator
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.